BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 167232)

  • 1. Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat.
    Zakheim RM; Mattioli L; Molteni A; Mullis KB; Bartley J
    Lab Invest; 1975 Jul; 33(1):57-61. PubMed ID: 167232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of chronic administration of the angiotensin I-converting enzyme inhibitor, Teprotide (SQ 20881), to affect the ultrastructure of the adrenal cortex and the aldosterone secretion in the rat.
    Weaver J; Nickerson PA; Molteni A; Solliday N; Albertson D
    Lab Invest; 1981 Dec; 45(6):527-33. PubMed ID: 6172661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in hypertension-induced protein synthesis in the rat pulmonary trunk after treatment with teprotide (SQ 20881).
    McKenzie JC; Hung KS; Mattioli L; Klein RM
    Proc Soc Exp Biol Med; 1984 Nov; 177(2):377-82. PubMed ID: 6207542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cilazapril, a novel angiotensin converting enzyme inhibitor, on the structure of pulmonary arteries of rats exposed to chronic hypoxia.
    Clozel JP; Saunier C; Hartemann D; Fischli W
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):36-40. PubMed ID: 1708054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the converting enzyme inhibitor SQ-20881 on urinary excretion of prostaglandin E2 in the rat: influence of pretreatment with deoxycorticosterone.
    Barr JG; Diz D; Kauker ML; Nasjletti A
    J Pharmacol Exp Ther; 1980 Oct; 215(1):172-5. PubMed ID: 6161243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hypoxia induced ultrastructural changes in the rat adrenal zona glomerulosa.
    Lorente M; Mirapeix RM; Miguel M; Longmei W; Volk D; Cervós-Navarro J
    Histol Histopathol; 2002 Jan; 17(1):185-90. PubMed ID: 11813868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man.
    Niarchos AP; Roberts AJ; Laragh JH
    Am J Med; 1979 Nov; 67(5):785-91. PubMed ID: 315711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubuloglomerular feedback and single nephron function after converting enzyme inhibition in the rat.
    Ploth DW; Rudulph J; LaGrange R; Navar LG
    J Clin Invest; 1979 Nov; 64(5):1325-35. PubMed ID: 227932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accentuated vascular and endocrine response to SQ 20881 in hypertension.
    Williams GH; Hollenberg NK
    N Engl J Med; 1977 Jul; 297(4):184-8. PubMed ID: 195203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the pulmonary arteries of the rat during recovery from hypoxia-induced pulmonary hypertension.
    Hislop A; Reid L
    Br J Exp Pathol; 1977 Dec; 58(6):653-62. PubMed ID: 147098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of converting enzyme blockade on isoprenaline- and angiotensin I-induced drinking.
    Hertting G; Meyer DK
    Br J Pharmacol; 1974 Nov; 52(3):381-6. PubMed ID: 4376436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of rat renin in sodium depleted and renal hypertensive rats. Comparison of purified antibodies or Fab fragments against mouse submaxillary renin with SQ 20881, and the effect on blood pressure homeostasis.
    Lykkegård S
    Scand J Urol Nephrol Suppl; 1984; 79():17-22. PubMed ID: 6206557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects on renal and submaxillary renin release after blockade of the renin system in mice.
    Bing J; Poulsen K
    Acta Pathol Microbiol Scand A; 1975 Nov; 83(6):733-6. PubMed ID: 171913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.
    Hislop A; Reid L
    Br J Exp Pathol; 1976 Oct; 57(5):542-54. PubMed ID: 136978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation.
    Okada K; Bernstein ML; Zhang W; Schuster DP; Botney MD
    Am J Respir Crit Care Med; 1998 Sep; 158(3):939-50. PubMed ID: 9731029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.
    Hollenberg NK; Swartz SL; Passan DR; Williams GH
    N Engl J Med; 1979 Jul; 301(1):9-12. PubMed ID: 221809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of peptides inhibiting the angiotensin-converting enzyme of human seminal plasma.
    Depierre D; Bargetzi JP; Roth M
    Enzyme; 1979; 24(6):362-5. PubMed ID: 230029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the inhibition of angiotensin converting enzyme on renin release mediated by exercise in man [proceedings].
    Khokhar AM; Havard CW; Slater JD
    J Endocrinol; 1979 Oct; 83(1):37P-38P. PubMed ID: 230274
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep.
    Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological changes in organs of rats chronically exposed to hypoxia. Development of pulmonary lipidosis.
    Wolman M; Cervós-Navarro J; Sampaolo S; Cardesa A
    Histol Histopathol; 1993 Apr; 8(2):247-55. PubMed ID: 8490251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.